The MB System is designed to naturally activate the body's own GLP-1 production, providing a range of long-term health benefits that expand to weight management and beyond.* Consumers worldwide are seeking sustainable health solutions that go beyond short-term, unsustainable weight management, said Steve Fife, President and CEO of LifeVantage
With DAC
Currently, nearly 100 million people globally are affected by DR, and as the prevalence of diabetes continues to rise, this number is expected to grow, posing a significant burden on public health (82)
Treatment with GLP-1MK-801 led to a decrease in plasma cholesterol levels compared with vehicle treatment and treatment with either GLP-1 or MK-801 (Fig
Eibye, E., et al., Implementation of pharmacist driven gabapentinoid titration for diabetic peripheral neuropathy in a primary care setting
Translational research further corroborates the link between a deficiency of LAC in clinical phenotypes of TRD and certain aspects of inflammation [51, 58]